Clinical Trial Update: A Study of Combination of Selinexor, Pomalidomide, and Dexamethasone (SPd) Versus Elotuzumab, Pomalidomide, and Dexamethasone (EloPd) in Subject With Previously Treated Multiple Myeloma [Phase 3]

View source ↗

Summary

This is a Phase 3 clinical trial comparing Selinexor, Pomalidomide, and Dexamethasone (SPd) against Elotuzumab, Pomalidomide, and Dexamethasone (EloPd) in adult…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Empliciti (elotuzumab)
• Pomalyst (pomalidomide)
• XPOVIO (selinexor)

Snippet

Sponsor: European Myeloma Network B.V. | Conditions: Multiple Myeloma | Phase 3 | Status: ACTIVE_NOT_RECRUITING